Buzzing Politics
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Select Page

What’s Going On With Velo3D Stock?

by Alex Perry | Feb 17, 2026

Velo3D, Inc. (NASDAQ:VELO) shares dropped sharply Tuesday morning despite announcing a new contract from a U.S. Defense prime contractor. Velo3D...

‘Dems Censor Info They Don’t Like, ‘Says The Man Who Gave Them $5 Million

by Parshwa Turakhiya | Feb 17, 2026

Sam Bankman-Fried attacked Democrats for censoring “misinformation” on social media and promoted Truth Social and GETTR as free speech platforms—a...

Bowman CEO Gary Bowman Announces Retirement

by Nabaparna Bhattacharya | Feb 17, 2026

Bowman Consulting Group (NASDAQ:BWMN) shares are trading lower on Tuesday following the announcement of founder and CEO Gary Bowman’s planned...

Rallybio Shares Successful Early-Stage Results for Rare Disease Drug; New Trial Set for Late 2026

by Vandana Singh | Feb 17, 2026

Rallybio Corporation (NASDAQ:RLYB) on Tuesday shared results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical trial of...

Celanese Likely To Report Lower Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

by Avi Kapoor | Feb 17, 2026

Celanese Corporation (NYSE:CE) will release earnings results for its fourth quarter, after the closing bell on Tuesday, Feb. 17. Analysts expect the...

Moderna Stock Rises After EU Marketing Authorization For mNEXSPIKE

by Dylan Berman | Feb 17, 2026

Moderna, Inc. (NASDAQ:MRNA) shares are trading higher Tuesday after the company announced European Commission marketing authorization for its...

Cathie Wood: Bitcoin’s Drop Driven By Algorithmic Selling, Not Fundamentals

by Khyathi Dalal | Feb 17, 2026

Ark Invest CEO Cathie Wood weighed in on Bitcoin's (CRYPTO: BTC) recent weakness, arguing that the decline reflects algorithmic selling rather than...

Small Cap Polaryx Picks Research Partner, Stock Surges on Phase 2 Trial Plans

by Vandana Singh | Feb 17, 2026

Polaryx Therapeutics Inc. (NASDAQ:PLYX) shares are up on Tuesday as the company has made significant strides in advancing its clinical programs. The...

Warner Bros Stock Climbs Tuesday: What’s Happening?

by Dylan Berman | Feb 17, 2026

Warner Bros. Discovery Inc. (NASDAQ:WBD) shares are trading higher Tuesday after the company set a March 20 special shareholder meeting to vote on...

Ford CEO Floats Bold China JV Plan To Trump Team

by Kaustubh Bagalkote | Feb 17, 2026

Ford Motor Co. (NYSE:F) CEO Jim Farley reportedly discussed with Trump administration’s senior officials regarding a potential roadmap for Chinese...

$100 Invested In iShares S&P 500 Growth ETF 20 Years Ago Would Be Worth This Much Today

by Benzinga Insights | Feb 17, 2026

iShares S&P 500 Growth ETF (NYSE:IVW) has outperformed the market over the past 20 years by 2.17% on an annualized basis producing an average...

Pfizer’s Cancer Drug Combo Shows Strong Results In Key Colorecatal Cancer Trial

by Vandana Singh | Feb 17, 2026

Pfizer Inc. (NYSE:PFE) on Tuesday shared news regarding its BRAFTOVI regimen for treating metastatic colorectal cancer. Pfizer announced that its...

Peter Schiff Says ‘Buy The Dips’ — As Gold’s Pullback Tests Conviction

by Surbhi Jain | Feb 17, 2026

Gold's rally just ran into its first real wave of selling pressure — and Peter Schiff is urging investors not to flinch. The pullback comes after a...

Kennedy-Wilson Set To Go Private In All-Cash Deal

by Lekha Gupta | Feb 17, 2026

Kennedy-Wilson Holdings Inc. (NYSE:KW) stock rose on Tuesday as the company entered into a definitive agreement to be acquired by a consortium led...

Sonoco Products Posts Upbeat Q4 Earnings, Joins Compass Pathways, Masimo, Itron And Other Big Stocks Moving Higher On Tuesday

by Avi Kapoor | Feb 17, 2026

U.S. stocks were lower, with the Nasdaq Composite falling around 1% on Tuesday. Shares of Sonoco Products Co (NYSE:SON) rose sharply during...

« Older Entries
Next Entries »
  • News
  • Privacy Policy
  • Terms of Use
  • Disclaimer
Copyright 2019 Karmaholic Media LLC. All Rights Reserved.